SCHEMBL16177752

SCHEMBL16177752

C=CCC(CCCC)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
CTSK P43235 6/20 0.38
CTSL P07711 3/20 0.36
CTSB P07858 2/20 0.36
CETP P11597 3/20 0.36
CNR2 P34972 1/20 0.36
PTGES O14684 1/20 0.36
ALOX5 P09917 1/20 0.36
CTSS P25774 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
RCE1 Q9Y256 1/20 0.35
CTSH P09668 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9685612 0.94 BCHE (0.42) BCHEACHECETPCNR2ALDH1A1
SCHEMBL9685558 0.94 BCHE (0.42) BCHEACHECETPCNR2ALDH1A1
SCHEMBL9684154 0.94 BCHE (0.42) BCHEACHECETPCNR2ALDH1A1
SCHEMBL9577155 0.87 SMN1; SMN2 (0.41) BCHESMN1; SMN2TSHRTDP1L3MBTL1
SCHEMBL9497399 0.87 SMN1; SMN2 (0.41) BCHESMN1; SMN2TSHRTDP1L3MBTL1
SCHEMBL30524953 0.85 CETP (0.42) CTSKCTSLCTSBCETPCNR2
SCHEMBL22490406 0.84 MEN1 (0.40) SMN1; SMN2ALDH1A1TSHRTDP1L3MBTL1
SCHEMBL17006171 0.84 LTA4H (0.38) BCHESMN1; SMN2ALDH1A1TSHRTDP1
SCHEMBL9685360 0.84 MAPT (0.39) BCHETDP1L3MBTL1
SCHEMBL1776277 0.84 SMN1; SMN2 (0.43) BCHESMN1; SMN2TSHRTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9586883-B2 Aldehyde-selective wacker-type oxidation of unbiased alkenes CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-03-07 US disclosed
US-9586883-B2 Aldehyde-selective wacker-type oxidation of unbiased alkenes CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-03-07 US disclosed
US-9586883-B2 Aldehyde-selective wacker-type oxidation of unbiased alkenes CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2017-03-07 US disclosed
US-20140316149-A1 ALDEHYDE-SELECTIVE WACKER-TYPE OXIDATION OF UNBIASED ALKENES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-10-23 US disclosed
US-20140316149-A1 ALDEHYDE-SELECTIVE WACKER-TYPE OXIDATION OF UNBIASED ALKENES CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2014-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140316149-A1 ALDEHYDE-SELECTIVE WACKER-TYPE OXIDATION OF UNBIASED ALKENES AOC2, ALDH2, ALDH3A1 BCHE 3252/4885ACHE 900/4885CTSK 3903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.